Age at dx (ys) & gender | Joint | FU (ms) | Duration of symptoms prior to dx (ms) | Serology | Imaging at presentation | Treatment | |
---|---|---|---|---|---|---|---|
X-ray | MRI | ||||||
14, F | L hip | 10 | 36 | ANA-; RF -; B27+ | Shortening of femoral neck, premature physis closure | Synovitis, ↓ joint space, ↓ cartilage | Naproxen, IAS x 2, MTX, Etanercept |
9, F | L hip | 5 | 5 | ANA+; RF-; B27+ | Normal | Synovitis, subchondral femoral head changes | Indomethacin |
16, F | R wrist | 10 | 8 | ANA-; RF- B27* | Normal | Synovitis, bone cysts, erosion | Naproxen, IAS x 3 |
9, F | L elbow | 5 | 11 | ANA+; RF- B27* | ↓ joint space, atrophy of the elbow complex | Synovitis, ballooning of the humeral epiphysis, multiple erosions | Naproxen, IAS |